These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

212 related items for PubMed ID: 3410937

  • 1. The effect of short term treatment with growth hormone and ethinyl estradiol on lower leg growth rate in girls with Turner's syndrome.
    Ross JL, Cassorla F, Carpenter G, Long LM, Royster MS, Loriaux DL, Cutler GB.
    J Clin Endocrinol Metab; 1988 Sep; 67(3):515-8. PubMed ID: 3410937
    [Abstract] [Full Text] [Related]

  • 2. Serum growth hormone (GH)-binding protein and insulin-like growth factor-I levels in Turner's syndrome before and during treatment with recombinant human GH and ethinyl estradiol.
    Massa G, Bouillon R, Vanderschueren-Lodeweyckx M.
    J Clin Endocrinol Metab; 1992 Nov; 75(5):1298-302. PubMed ID: 1430092
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Improved final height in girls with Turner's syndrome treated with growth hormone and oxandrolone.
    Nilsson KO, Albertsson-Wikland K, Alm J, Aronson S, Gustafsson J, Hagenäs L, Häger A, Ivarsson SA, Karlberg J, Kriström B, Marcus C, Moell C, Ritzen M, Tuvemo T, Wattsgård C, Westgren U, Westphal O, Aman J.
    J Clin Endocrinol Metab; 1996 Feb; 81(2):635-40. PubMed ID: 8636281
    [Abstract] [Full Text] [Related]

  • 6. Specific, time-dependent actions of low-dose ethinyl estradiol administration on the episodic release of growth hormone, follicle-stimulating hormone, and luteinizing hormone in prepubertal girls with Turner's syndrome.
    Mauras N, Rogol AD, Veldhuis JD.
    J Clin Endocrinol Metab; 1989 Nov; 69(5):1053-8. PubMed ID: 2507569
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Final height in girls with Turner's syndrome treated with once or twice daily growth hormone injections. Dutch Advisory Group on Growth Hormone.
    Sas TC, de Muinck Keizer-Schrama SM, Stijnen T, van Teunenbroek A, Hokken-Koelega AC, Waelkens JJ, Massa GG, Vulsma T, Gerver WJ, Reeser HM, Delemarre-van de Waal HE, Jansen M, Drop SL.
    Arch Dis Child; 1999 Jan; 80(1):36-41. PubMed ID: 10325756
    [Abstract] [Full Text] [Related]

  • 11. Comparative study of the changes in insulin-like growth factor-I, procollagen-III N-terminal extension peptide, bone Gla-protein, and bone mineral content in children with Turner's syndrome treated with recombinant growth hormone.
    Bergmann P, Valsamis J, Van Perborgh J, De Schepper J, Van Vliet G.
    J Clin Endocrinol Metab; 1990 Dec; 71(6):1461-7. PubMed ID: 2229302
    [Abstract] [Full Text] [Related]

  • 12. Effects of acute high dose and chronic low dose estrogen on plasma somatomedin-C and growth in patients with Turner's syndrome.
    Copeland KC.
    J Clin Endocrinol Metab; 1988 Jun; 66(6):1278-82. PubMed ID: 3372687
    [Abstract] [Full Text] [Related]

  • 13. Growth hormone treatment in Turner's syndrome: short and long-term effects on metabolic parameters.
    Haeusler G, Frisch H.
    Clin Endocrinol (Oxf); 1992 Mar; 36(3):247-53. PubMed ID: 1563078
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Estrogen therapy in Turner's syndrome.
    Cutler GB, Ross JL.
    Acta Paediatr Jpn; 1992 Apr; 34(2):195-202; discussion 202-5. PubMed ID: 1621525
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Growth hormone therapy in Turner's syndrome: an update on final height. Genentech National Cooperative Study Group.
    Rosenfeld RG.
    Acta Paediatr Suppl; 1992 Sep; 383():3-6; discussion 7. PubMed ID: 1458013
    [Abstract] [Full Text] [Related]

  • 18. Bone mineral density assessed by phalangeal radiographic absorptiometry before and during long-term growth hormone treatment in girls with Turner's syndrome participating in a randomized dose-response study.
    Sas TC, de Muinck Keizer-Schrama SM, Stijnen T, van Teunenbroek A, van Leeuwen WJ, Asarfi A, van Rijn RR, Drop SL, Dutch Advisory Group on Growth Hormone.
    Pediatr Res; 2001 Sep; 50(3):417-22. PubMed ID: 11518831
    [Abstract] [Full Text] [Related]

  • 19. Increased hGH production rate after low-dose estrogen therapy in prepubertal girls with Turner's syndrome.
    Mauras N, Rogol AD, Veldhuis JD.
    Pediatr Res; 1990 Dec; 28(6):626-30. PubMed ID: 2284161
    [Abstract] [Full Text] [Related]

  • 20. A longitudinal study on bone mineral density until adulthood in girls with Turner's syndrome participating in a growth hormone injection frequency-response trial.
    Sass TC, De Muinck Keizer-Schrama SM, Stijnen T, Asarfi A, Van Leeuwen WJ, Van Teunenbroek A, Van Rijn RR, Drop SL.
    Clin Endocrinol (Oxf); 2000 May; 52(5):531-6. PubMed ID: 10792330
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.